Technology News and Research

RSS

Texas A&M uses pGAP and IBM supercomputing technology to boost tuberculosis research

IBM today announced that Texas A&M University used IBM supercomputing technology to carry out potentially life-saving tuberculosis research at a rate more than four times faster than was previously possible.

2 Jun 2010

New recommendations can lower radiation exposure for patients undergoing MPI procedures: ASNC

New recommendations published by the American Society of Nuclear Cardiology (www.asnc.org) could significantly lower radiation exposure for patients undergoing myocardial perfusion imaging (MPI) procedures. Focused on three areas — patient selection, test selection, and technology adoption — ASNC's information statement summarizes best practices for minimizing radiation exposure without sacrificing quality or clinical benefit to the patient.

2 Jun 2010

Pioneer announces presentation of NuBac IDE feasibility study 2-year follow up results at 10th SAS meeting

Pioneer Surgical Technology, Inc. is pleased to announce that the clinical results of the two-year follow up on the NuBac IDE feasibility study patients was presented at the recent 10th annual meeting of The International Society for the Advancement of Spine Surgery (SAS) in New Orleans by Domagoj Coric, M.D., Chief, Department of Neurosurgery, Carolina's Medical Center.

2 Jun 2010

MSI Surgical Solutions adds three new autoclaves to expand ETO sterilization capabilities

MSI Surgical Solutions, an Empire Investment Holdings company, announced today that it has expanded its ETO (Ethylene Oxide) sterilization capabilities through the addition of three new autoclaves. ETO machines are critical in the sterilization of both disposable and reusable items made of rubber or paper products, items that are sensitive to heat or moisture and medical device components including probes, scopes, tubes, cords, wires and leads.

2 Jun 2010

TU Delft, MI Labs combine microPET and microSPECT into Versatile Emission Computed Tomography device

TU Delft and Molecular Imaging Labs (MI Labs) have succeeded in combining two forms of medical imaging techniques into one piece of equipment. These techniques are particularly useful for cancer research.

2 Jun 2010

Naples Diagnostic Imaging Centers to deploy IntelePACS Breast Imaging digital mammography solution

Intelerad® Medical Systems, a leader in medical imaging PACS and workflow solutions, today announced that Naples Diagnostic Imaging Centers will be replacing its current mammography workstations with the IntelePACS® Breast Imaging digital mammography solution.

2 Jun 2010

US Oncology introduces new KnowMed Technology Platform to support oncologists nationwide

US Oncology, Inc., the nation's leading integrated oncology company, today announced its new iKnowMed™ Technology Platform to support community oncologists nationwide. This new platform enhances cancer care quality and practice efficiency through integrated, oncology-specific technologies that enable community oncologists to solve challenges in the areas of care delivery, drug management, and revenue cycle management.

2 Jun 2010

TapImmune signs Licensing Option agreement with Mayo Clinic for breast cancer vaccine technology

TapImmune Inc. announced that it has signed an exclusive Licensing Option agreement with Mayo Clinic, Rochester, MN, for clinical development of a breast cancer vaccine technology. The option to license this technology can be exercised after Phase I clinical trials under terms agreed between Mayo Clinic and TapImmune.

2 Jun 2010

Latinos have highest rates of eye disease: New research

New research suggests Latinos have the highest rates of eye disease in the United States, and one Los Angeles area clinic, Eye Physicians of Long Beach, is supremely prepared to meet the community's eye care needs.

2 Jun 2010

Postdoctoral scientists receive NYSCF-Druckenmiller Fellowship award

The New York Stem Cell Foundation (NYSCF) today announced the award of eight new NYSCF-Druckenmiller Fellows. These postdoctoral scientists join 15 accomplished stem cell researchers from leading institutions who have been supported by the program since 2006. NYSCF has awarded 23 fellowships to date.

2 Jun 2010

Tetraphase Pharmaceuticals raises $45M in Series C financing

Tetraphase Pharmaceuticals, a clinical stage biopharmaceutical company utilizing breakthrough synthetic chemistry technology to discover and develop next-generation antibiotics, today announced that it has raised $45 million in a Series C financing.

2 Jun 2010

Encision enters into purchasing agreement with HealthTrust

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, announced today that it has entered into a purchasing agreement with HealthTrust Purchasing Group, LP, effective June 1, 2010.

2 Jun 2010

Results from AMRI's on-going Phase I clinical study of ALB 109564(a) published online

AMRI announced today that on-going results from its Phase I clinical study on its novel tubulin inhibitor, ALB 109564(a), were published on the website of the American Society of Clinical Oncology (abstract.asco.org/alb). These results indicate that ALB 109564(a) is well tolerated at the doses tested and shows preliminary evidence of clinical activity in disease types not typically treated with approved vinca alkaloids.

2 Jun 2010

Firms chase opportunities in online medicine

General Electric Co. chief executive Jeffrey Immelt urged Japan, at a conference in Tokyo Monday, to use health information technology to improve home-based health care as a hedge against the strains of an aging population, The Wall Street Journal reports. Japan's over-65 population is growing, and could top 30 percent by 2030.

2 Jun 2010

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin.

2 Jun 2010

NanoPowers announces closing of CHF 5 million series A financing

NanoPowers SA, a medical device company that leverages its unique artificial muscle technology to restore or improve muscle function, today announced the closing of a CHF 5 million ($4.5 million) series A financing. The financing round was led by Novartis Venture Funds. Also participating in the financing were Initiative Capital Romandie and Gran Plasa SA.

1 Jun 2010

PAREXEL International establishes new brand identity "Right Where You Need Us"

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has established the new brand identity "Right Where You Need Us," which reflects various transformation initiatives focused on meeting the diverse requirements of the Company's clients.

From Parexel 1 Jun 2010

OrthoDynamix releases disposable biter for meniscal shoulder, knee repair

OrthoDynamix announces a line extension to their sports medicine portfolio. The ArthroSteer Biter is the first ever disposable biter used for meniscal shoulder and knee repair. A sharp jaw for every procedure affords the ultimate tissue interaction. Moreover, the Biter is steerable, allowing access to and around joint capsule structures.

1 Jun 2010

GE Healthcare introduces new CESM technology to aid in breast cancer diagnosis

GE Healthcare, a pioneer in digital mammography, today announced the introduction of an innovative technology to aid in breast cancer diagnosis. GE Healthcare's new SenoBright Contrast Enhanced Spectral Mammography technology reduces ambiguity in mammography results, enabling physicians to detect and diagnose cancer with more confidence - even in the densest part of the breast tissue more rapidly and accurately.

1 Jun 2010

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Targeted Genetics Corporation today announced its financial results for the fourth quarter and full year ended December 31, 2009.

1 Jun 2010

Technology News and Research

Texas A&M uses pGAP and IBM supercomputing technology to boost tuberculosis research

New recommendations can lower radiation exposure for patients undergoing MPI procedures: ASNC

Pioneer announces presentation of NuBac IDE feasibility study 2-year follow up results at 10th SAS meeting

MSI Surgical Solutions adds three new autoclaves to expand ETO sterilization capabilities

TU Delft, MI Labs combine microPET and microSPECT into Versatile Emission Computed Tomography device

Naples Diagnostic Imaging Centers to deploy IntelePACS Breast Imaging digital mammography solution

US Oncology introduces new KnowMed Technology Platform to support oncologists nationwide

TapImmune signs Licensing Option agreement with Mayo Clinic for breast cancer vaccine technology

Latinos have highest rates of eye disease: New research

Postdoctoral scientists receive NYSCF-Druckenmiller Fellowship award

Tetraphase Pharmaceuticals raises $45M in Series C financing

Encision enters into purchasing agreement with HealthTrust

Results from AMRI's on-going Phase I clinical study of ALB 109564(a) published online

Firms chase opportunities in online medicine

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

NanoPowers announces closing of CHF 5 million series A financing

PAREXEL International establishes new brand identity "Right Where You Need Us"

OrthoDynamix releases disposable biter for meniscal shoulder, knee repair

GE Healthcare introduces new CESM technology to aid in breast cancer diagnosis

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News